Specializing in human tissue engineering, the biotech CTIBiotech, located in Meyzieu (Rhône) recently announced a new investment of 3 million euros. Supported by Bpifrance, the operation aims to strengthen the development and industrialization of its 3D microtumour printing system.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Specializing in human tissue engineering, the biotech CTIBiotech, located in Meyzieu (Rhône) recently announced a new investment of 3 million euros. Supported by Bpifrance, the operation aims to strengthen the development and industrialization of its 3D microtumour printing system.